novogen - why isn't anyone interested

I can't believe the lack of support for Novogen stock. Some possible reasons are:

1) Biotech investors are bored with the big boys in the sector and are more interested in the smaller biotech.

2) People selling purely on a technical basis after it punched below the trend line.

3) Lack of announcements in the recent past, and some might say foreseeable future.

My comment is that Novogen is a "slow" company by way of announcements but their core assets look quite solid. The market cap is around $450m but this is quite justified looking at where they are up too.

The article found last night which commented on the ovarian cancer trial has attracted little interest, both in the US and in trading today. Why? Do people think a 20-30% response isn't good?

Anyhow, longer term Novogen should do very well but it can be very frustrating holding the stock and see it get chipped away lower on low volume. I know, Ilve held it long enough.

Any ideas why Novogen didn't make a public statement?

Come on Novogen come on come on. Come on Novogen come on.

Cheers,
Munch.,